Overview of drug resistance

Drug resistance refers to the resistance of pathogens (such as bacteria, viruses, parasites) or tumor cells to drugs, resulting in reduced or ineffective drug efficacy. This phenomenon is particularly common in antibiotic abuse and anti-tumor treatment, and may trigger a public health crisis. The mechanisms of drug resistance include genetic mutations, changes in drug targets, or adjustments in metabolic pathways. The primary and secondary structures are as follows:

• core issues: Over-medication and incorrect medication are the main causes of drug resistance;
• secondary factors: The widespread use of antibiotics in agriculture and animal husbandry accelerates the spread of drug resistance.

The formation and harm of drug resistance

When drugs are used frequently, a small number of individuals with drug-resistant genes among the pathogens survive and multiply, eventually forming a drug-resistant population. For example,Methicillin-resistant Staphylococcus aureus (MRSA)It is ineffective against many antibiotics, making treatment more difficult. According to data from the World Health Organization (WHO), approximately 700,000 people die from drug-resistant bacterial infections every year. If left unchecked, drug resistance could cost the global economy US$100 trillion by 2050.

Prevention and control measures for drug resistance

Reducing drug resistance requires a multi-pronged approach:Rational use of medicationis the key. Patients should avoid buying antibiotics on their own; medical institutions need to strengthen infection prevention and control; and the agricultural field should limit the use of antibiotics as growth promoters. For example, after the European Union completely banned the addition of antibiotics to feed in 2006, the proportion of animal-derived drug-resistant bacteria dropped significantly.

Drug resistance related products and research progress

Pharmaceutical companies are developing new antibacterial drugs to combat drug resistance, such as Pfizer'sAztec (Aztreonam)Combined with beta-lactamase inhibitors. In addition, rapid diagnostic technologies (such as gene sequencing) can help with precise drug administration. The table below lists some of the products that address drug resistance:

Summary and Outlook

Drug resistance is a global health challenge that requires coordinated responses by individuals, healthcare systems, and policies. In the future, it is necessary to accelerate the research and development of new drugs, and at the same time promote vaccine prevention and alternative therapies (such as phage therapy). Public education is also crucial to avoid misunderstandings such as “antibiotics cure colds”.

Citing sources: World Health Organization (WHO) "Global Report on Antimicrobial Resistance"; "The Lancet" Special Issue on Resistance Research; Pfizer and Eli Lilly and Company official website product data.